Skip to main content
California Medicine logoLink to California Medicine
. 1961 Feb;94(2):88–92.

FATAL EPISTAXIS

Francis Berchmans Quinn Jr
PMCID: PMC1575459  PMID: 13738727

Abstract

The instances in which nosebleed is potentially fatal are those in which there is a history of recent head injury, severe arteriosclerotic cardiovascular disease or an underlying vascular tumor in the nasal chambers. Fatal nasal bleeding has not been reported in children. An awareness on the part of the physician of the potentially fatal significance of his patient's nosebleed is the very best insurance against such an event. Intelligent history-taking, careful physical and x-ray examination, generous sedation, precise local cauterization and packing, estimation of hemoglobin mass and a search for bleeding and clotting disorders are the best weapons of the physician called to treat epistaxis. These procedures, coupled with adequate blood replacement and an informed attitude toward surgical interruption of the blood supply to the bleeding region should forestall death from fatal nosebleed.

Full text

PDF
88

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEINFIELD H. H. General principles in treatment of nasal hemorrhage; emphasis on management of postnasal hemorrhage. AMA Arch Otolaryngol. 1953 Jan;57(1):51–59. doi: 10.1001/archotol.1953.00710030068006. [DOI] [PubMed] [Google Scholar]
  2. BOURDON E. Leucose aigue monosymptomatique (epistaxis). Ann Otolaryngol. 1952 Oct;69(10):607–608. [PubMed] [Google Scholar]
  3. HRENOFF A. K. Hexamethonium contributing to fatal shock in hypertensive epistaxis. Calif Med. 1954 Dec;81(6):417–418. [PMC free article] [PubMed] [Google Scholar]
  4. RASQUIN P. Un cas rare d'hémorragie nasale mortelle. Ann Otolaryngol. 1949 Sep;66(9):445–449. [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES